Related Experiment Video
Updated: Aug 5, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
[Biphosphonates and intraocular inflammation]
V M Asensio Sánchez1, G Botella Oltra, E Carrasco
1Hospital General, Medina del Campo, Valladolid, Spain.
Unlabelled:
PURPOSE/MATERIAL AND METHOD: A 67 year old woman had been taking oral alendronate in a single weekly dose of 70 mg. She developed panuveitis in her right eye and anterior uveitis in the left. The uveitis was resolved with steroids and discontinuation of alendronate. Three weeks later alendronate was reinstituted and this produced a recurrence. Her past medical history revealed that she had a temporal arteritis but her past ocular history was unremarkable.
Results/Conclusion:
Disodium alendronate can cause intraocular inflammation (panuveitis and anterior uveitis), which requires discontinuing the treatment.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Ophthalmic Drug Delivery Systems

